StockGuru Spotlight August 15, 2011: EPAZ Up As Much As 25%; BAZI Up As Much As 51%; TTNP Up As Much As 20% in a Week

StockGuru Spotlight  August 15, 2011:  EPAZ Up As Much As 25%; BAZI Up As Much As 51%; TTNP Up As Much As 20% in a Week

StockGuru Spotlight

August 15, 2011


Dear Members:

These Spotlights have made tremendous moves. As you can see, StockGuru brings you the very stocks you want on your radar, in your portfolio and to trade.

StockGuru Spotlight Spotlight Price Symbol High Up As Much As Market Cap
June 30, 2011  $    0.04 EPAZ  $    0.05 25% $1.65M
August 9, 2011  $    0.72 JAMN  $    0.884 23% $67.84M
June 24, 2011  $    0.11 BAZI  $    0.17 55% $5.51M
July 10, 2011  $    1.84 SGAE  $    2.44 33% $98.09M
August 10, 2011  $    1.52 TTNP  $    1.83 20% $108.42M
August 11, 2011  $    0.20 NJMC  $    0.22 10%

Siga Resources Inc.  (OTCBB SGAE) was founded in 2007, and is based in South Lake Tahoe, California. Siga is a mineral resource exploration and development company. Siga’s strategy targets properties that have the potential for near term production and early positive cash flow. Siga’s general geographical interest is North and South America . Bentley Fairview Resources Co. Ltd., of Ontario, Canada, the Joint Venture Partner for the Big Bear Mining Claims located in San Bernardino County, California, has advanced the initial payment for the initiation of a work program on the Big Bear Mining Claims. This is the initial payment of a $10,000,000 Joint Venture entered by the two companies with the goal of proving the indicated gold resources on the Big Bear claims and if warranted, developing the Big Bear property to possible production. Siga’s work program and the beginning of evaluation of the project are underway as of Aug 3, 2011.

Titan Pharmaceuticals, Inc. (OTCBB: TTNP) will host a live conference call TOMORROW — at 11 a.m. ET / 8 a.m. PT on Tuesday, August 16, 2011. You might want to put this on your calendar.  This Company is looking strong.

Titan will provide the Company’s financial results as of June 30, 2011 and, as previously announced, discuss results of its recently reported positive Phase 3 clinical trial of Probuphine in patients with opioid dependence. The call will be hosted by Sunil Bhonsle, President, Katherine Beebe, Ph.D., Executive Vice President and Chief Development Officer, and Marc Rubin, M.D., Executive Chairman. Joining the Titan management team for the call will be:

  • Walter Ling, M.D., Professor of Psychiatry and Director, Integrated Substance Abuse Programs at the David Geffen School of Medicine at UCLA and a lead investigator in the Probuphine Phase 3 study
  • Richard N. Rosenthal, M.D., Chairman of Psychiatry at St.Luke’s-Roosevelt Hospital Center, a teaching hospital of Columbia University, past president of the American Academy of Addiction Psychiatry and a lead investigator in the Phase 3 study

IMPORTANT: Bookmark this link: Check This Link Every Morning for New Spotlight StocksAll of these are date and time stamped so you know what is current today. You can also just go to STOCKGURU.COM and look for the link in the top navigation for “StockGuru Spotlight.” You can also put the RSS link into your RSS reader9, such as my favorite “Google Reader.”

There are countless programs that make it easy to get RSS feeds on your wireless phone as well. This is foolproof BUT ONLY IF YOU CHECK YOUR RSS FEED REGULARLY! RSS link on the site. We do not yet send out Spotlight Alerts by email, in an attempt to give your email box a break. Spotlights occur several times weekly, and are released ONLY when we see a valid reason. Occasionally, our Spotlights are compensated picks, but an editorial decision is made as to whether the situation qualifies as a market sensitive pick and we ALWAYS include a disclosure prominently if we include a company for which we have been compensated in either cash or shares.

StockGuru is in its Ninth Year!